Now is the Time to Improve Cognitive Screening and Assessment for Clinical and Research Advancement

J. Wesson Ashford; Frederick A. Schmitt; Michael F. Bergeron; Peter J. Bayley; James O. Clifford; Qun Xu; Xiaolei Liu; Xianbo Zhou; Vinod Kumar; Herman Buschke; Margaret Dean; Sanford I. Finkel; Lee Hyer; George Perry

doi:10.3233/JAD-220211

Now is the Time to Improve Cognitive Screening and Assessment for Clinical and Research Advancement

J. Wesson Ashford, Frederick A. Schmitt, Michael F. Bergeron, Peter J. Bayley, James O. Clifford, Qun Xu, Xiaolei Liu, Xianbo Zhou, Vinod Kumar, Herman Buschke, Margaret Dean, Sanford I. Finkel, Lee Hyer, George Perry

Neurology

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Abstract

Wang et al. analyze Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment accuracy as screening tests for detecting dementia associated with Alzheimer's disease (AD). Such tests are at the center of controversy regarding recognition and treatment of AD. The continued widespread use of tools such as MMSE (1975) underscores the failure of advancing cognitive screening and assessment, which has hampered the development and evaluation of AD treatments. It is time to employ readily available, efficient computerized measures for population/mass screening, clinical assessment of dementia progression, and accurate determination of approaches for prevention and treatment of AD and related conditions.

Original language	English (US)
Pages (from-to)	305-315
Number of pages	11
Journal	Journal of Alzheimer's Disease
Volume	87
Issue number	1
DOIs	https://doi.org/10.3233/JAD-220211
State	Published - 2022

Keywords

Alzheimer's disease
MemTrax
Mini-Mental State Examination
Montreal Cognitive Assessment
cognition assessment
computerized testing
neuroplasticity

ASJC Scopus subject areas

General Neuroscience
Clinical Psychology
Geriatrics and Gerontology
Psychiatry and Mental health

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3233/JAD-220211

Cite this

Ashford, J. W., Schmitt, F. A., Bergeron, M. F., Bayley, P. J., Clifford, J. O., Xu, Q., Liu, X., Zhou, X., Kumar, V., Buschke, H., Dean, M., Finkel, S. I., Hyer, L., & Perry, G. (2022). Now is the Time to Improve Cognitive Screening and Assessment for Clinical and Research Advancement. Journal of Alzheimer's Disease, 87(1), 305-315. https://doi.org/10.3233/JAD-220211

@article{16038aedb1744f77a57330d46a2f74d7,

title = "Now is the Time to Improve Cognitive Screening and Assessment for Clinical and Research Advancement",

abstract = "Wang et al. analyze Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment accuracy as screening tests for detecting dementia associated with Alzheimer's disease (AD). Such tests are at the center of controversy regarding recognition and treatment of AD. The continued widespread use of tools such as MMSE (1975) underscores the failure of advancing cognitive screening and assessment, which has hampered the development and evaluation of AD treatments. It is time to employ readily available, efficient computerized measures for population/mass screening, clinical assessment of dementia progression, and accurate determination of approaches for prevention and treatment of AD and related conditions.",

keywords = "Alzheimer's disease, MemTrax, Mini-Mental State Examination, Montreal Cognitive Assessment, cognition assessment, computerized testing, neuroplasticity",

author = "Ashford, {J. Wesson} and Schmitt, {Frederick A.} and Bergeron, {Michael F.} and Bayley, {Peter J.} and Clifford, {James O.} and Qun Xu and Xiaolei Liu and Xianbo Zhou and Vinod Kumar and Herman Buschke and Margaret Dean and Finkel, {Sanford I.} and Lee Hyer and George Perry",

year = "2022",

doi = "10.3233/JAD-220211",

language = "English (US)",

volume = "87",

pages = "305--315",

journal = "Journal of Alzheimer's Disease",

issn = "1387-2877",

publisher = "IOS Press",

number = "1",

}

TY - JOUR

T1 - Now is the Time to Improve Cognitive Screening and Assessment for Clinical and Research Advancement

AU - Ashford, J. Wesson

AU - Schmitt, Frederick A.

AU - Bergeron, Michael F.

AU - Bayley, Peter J.

AU - Clifford, James O.

AU - Xu, Qun

AU - Liu, Xiaolei

AU - Zhou, Xianbo

AU - Kumar, Vinod

AU - Buschke, Herman

AU - Dean, Margaret

AU - Finkel, Sanford I.

AU - Hyer, Lee

AU - Perry, George

PY - 2022

Y1 - 2022

N2 - Wang et al. analyze Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment accuracy as screening tests for detecting dementia associated with Alzheimer's disease (AD). Such tests are at the center of controversy regarding recognition and treatment of AD. The continued widespread use of tools such as MMSE (1975) underscores the failure of advancing cognitive screening and assessment, which has hampered the development and evaluation of AD treatments. It is time to employ readily available, efficient computerized measures for population/mass screening, clinical assessment of dementia progression, and accurate determination of approaches for prevention and treatment of AD and related conditions.

AB - Wang et al. analyze Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment accuracy as screening tests for detecting dementia associated with Alzheimer's disease (AD). Such tests are at the center of controversy regarding recognition and treatment of AD. The continued widespread use of tools such as MMSE (1975) underscores the failure of advancing cognitive screening and assessment, which has hampered the development and evaluation of AD treatments. It is time to employ readily available, efficient computerized measures for population/mass screening, clinical assessment of dementia progression, and accurate determination of approaches for prevention and treatment of AD and related conditions.

KW - Alzheimer's disease

KW - MemTrax

KW - Mini-Mental State Examination

KW - Montreal Cognitive Assessment

KW - cognition assessment

KW - computerized testing

KW - neuroplasticity

UR - http://www.scopus.com/inward/record.url?scp=85130000730&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85130000730&partnerID=8YFLogxK

U2 - 10.3233/JAD-220211

DO - 10.3233/JAD-220211

M3 - Article

C2 - 35431257

AN - SCOPUS:85130000730

SN - 1387-2877

VL - 87

SP - 305

EP - 315

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

IS - 1

ER -

Now is the Time to Improve Cognitive Screening and Assessment for Clinical and Research Advancement

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this